Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Biotech ETF BBH

  • Full Name: Market Vectors®
    Biotech ETF (BBH)

    Management Style: Replication

    Underlying Index: Market Vectors® US Listed Biotech 25 Index (MVBBHTR)

    Index Description: MVBBHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.

  •  
     

    • Fund Ticker

      BBH
    • Exchange

      NYSE Arca
    • Index Total Return Ticker

      MVBBHTR
    • Index Provider

      Market Vectors Index Solutions
    • Total Net Assets

      $496.2M
    • Shares Outstanding

      5,796,503
    • Number of Holdings

      26
    • Commencement Date

      12/20/2011
  •  
    as of 04/16/14

  • Portfolio Composition (%)
    as of 04/16/14

    • % of Net Assets

    • Stocks

      99.99
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.01
    • Total

      100.00
  • Download All Holdings All Holdings (%) as of 04/16/14

    Total Holdings: 26
    Holding Name
    Ticker
    Shares Market Value
    (US$)
    % of Net
    Assets
    Gilead Sciences Inc
    GILD US
    892,637
    61,841,891 12.46
    Amgen Inc
    AMGN US
    490,172
    56,634,473 11.41
    Biogen Idec Inc
    BIIB US
    153,475
    44,734,893 9.01
    Celgene Corp
    CELG US
    309,047
    43,841,407 8.83
    Regeneron Pharmaceuticals Inc
    REGN US
    86,101
    25,842,354 5.21
    Alkermes Plc
    ALKS US
    563,001
    25,351,935 5.11
    Alexion Pharmaceuticals Inc
    ALXN US
    164,042
    24,450,460 4.93
    Vertex Pharmaceuticals Inc
    VRTX US
    329,372
    21,208,263 4.27
    Illumina Inc
    ILMN US
    155,311
    21,156,464 4.26
    Biomarin Pharmaceutical Inc
    BMRN US
    317,652
    19,494,303 3.93
    Qiagen Nv
    QGEN US
    862,404
    17,541,297 3.53
    Incyte Corp Ltd
    INCY US
    367,568
    16,165,641 3.26
    Isis Pharmaceuticals Inc
    ISIS US
    458,838
    15,862,030 3.20
    Pharmacyclics Inc
    PCYC US
    140,466
    12,647,559 2.55
    Covance Inc
    CVD US
    128,530
    12,583,087 2.54
    United Therapeutics Corp
    UTHR US
    125,945
    12,370,318 2.49
    Medivation Inc
    MDVN US
    202,492
    11,914,629 2.40
    Cubist Pharmaceuticals Inc
    CBST US
    177,795
    11,366,434 2.29
    Charles River Laboratories Internationa
    CRL US
    141,414
    8,148,275 1.64
    Cepheid Inc
    CPHD US
    137,693
    6,552,810 1.32
    Intercept Pharmaceuticals Inc
    ICPT US
    26,647
    6,328,929 1.28
    Myriad Genetics Inc
    MYGN US
    153,285
    5,875,414 1.18
    Nps Pharmaceuticals Inc
    NPSP US
    214,540
    5,331,319 1.07
    Seattle Genetics Inc
    SGEN US
    120,011
    4,628,824 0.93
    Ariad Pharmaceuticals Inc
    ARIA US
    611,608
    4,339,359 0.87
    Other/Cash
    32,036 0.01
    Total (%) 99.98
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.